These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24788801)

  • 1. Profile of adverse events in patients receiving treatment for malaria in urban Ghana: a cohort-event monitoring study.
    Dodoo AN; Fogg C; Nartey ET; Ferreira GL; Adjei GO; Kudzi W; Sulley AM; Kodua A; Ofori-Adjei D
    Drug Saf; 2014 Jun; 37(6):433-48. PubMed ID: 24788801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy.
    Dodoo AN; Fogg C; Asiimwe A; Nartey ET; Kodua A; Tenkorang O; Ofori-Adjei D
    Malar J; 2009 Jan; 8():2. PubMed ID: 19123926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of a fixed-dose combination of artesunate and amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in real-life conditions of use in Côte d'Ivoire.
    Assi SB; Aba YT; Yavo JC; Nguessan AF; Tchiekoi NB; San KM; Bissagnéné E; Duparc S; Lameyre V; Tanoh MA
    Malar J; 2017 Jan; 16(1):8. PubMed ID: 28049523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-malarial drug safety information obtained through routine monitoring in a rural district of South-Western Senegal.
    Brasseur P; Vaillant MT; Olliaro PL
    Malar J; 2012 Dec; 11():402. PubMed ID: 23216982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety monitoring of artemisinin combination therapy through a national pharmacovigilance system in an endemic malaria setting.
    Thiam S; Ndiaye JL; Diallo I; Gatonga P; Fall FB; Diallo NE; Faye B; Diouf ML; Ndiop M; Diouf MB; Gaye O; Thior M
    Malar J; 2013 Feb; 12():54. PubMed ID: 23384036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of Artemisinin-Based Combination Therapies in Nigeria: A Cohort Event Monitoring Study.
    Bassi PU; Osakwe AI; Isah A; Suku C; Kalat M; Jalo I; Wammanda RD; Ugochukwu C; Adesina O; Nyong EE; Osungwu F; Pal S; Nwoasu SC; Wallberg M; Coulter D
    Drug Saf; 2013 Sep; 36(9):747-56. PubMed ID: 23591829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring antimalarial safety and tolerability in clinical trials: a case study from Uganda.
    Staedke SG; Jagannathan P; Yeka A; Bukirwa H; Banek K; Maiteki-Sebuguzi C; Clark TD; Nzarubara B; Njama-Meya D; Mpimbaza A; Rosenthal PJ; Kamya MR; Wabwire-Mangen F; Dorsey G; Talisuna AO
    Malar J; 2008 Jun; 7():107. PubMed ID: 18547416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and cost of using mobile phones for capturing drug safety information in peri-urban settlement in Ghana: a prospective cohort study of patients with uncomplicated malaria.
    Kukula VA; Dodoo AA; Akpakli J; Narh-Bana SA; Clerk C; Adjei A; Awini E; Manye S; Nagai RA; Odonkor G; Nikoi C; Adjuik M; Akweongo P; Baiden R; Ogutu B; Binka F; Gyapong M
    Malar J; 2015 Oct; 14():411. PubMed ID: 26481106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paediatric pharmacovigilance: use of pharmacovigilance data mining algorithms for signal detection in a safety dataset of a paediatric clinical study conducted in seven African countries.
    Kajungu DK; Erhart A; Talisuna AO; Bassat Q; Karema C; Nabasumba C; Nambozi M; Tinto H; Kremsner P; Meremikwu M; D'Alessandro U; Speybroeck N
    PLoS One; 2014; 9(5):e96388. PubMed ID: 24787710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety Experience During Real-World Use of Injectable Artesunate in Public Health Facilities in Ghana and Uganda: Outcomes of a Modified Cohort Event Monitoring Study (CEMISA).
    Ampadu HH; Dodoo ANO; Bosomprah S; Akakpo S; Hugo P; Gardarsdottir H; Leufkens HGM; Kajungu D; Asante KP
    Drug Saf; 2018 Sep; 41(9):871-880. PubMed ID: 29696507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malaria pharmacovigilance in Africa: lessons from a pilot project in Mpumalanga Province, South Africa.
    Mehta U; Durrheim D; Mabuza A; Blumberg L; Allen E; Barnes KI
    Drug Saf; 2007; 30(10):899-910. PubMed ID: 17867727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experiences and Lessons From Implementing Cohort Event Monitoring Programmes for Antimalarials in Four African Countries: Results of a Questionnaire-Based Survey.
    Suku CK; Hill G; Sabblah G; Darko M; Muthuri G; Abwao E; Pandit J; Osakwe AI; Elagbaje C; Nyambayo P; Khoza S; Dodoo AN; Pal SN
    Drug Saf; 2015 Nov; 38(11):1115-26. PubMed ID: 26267842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a pharmacovigilance safety monitoring tool for the rollout of single low-dose primaquine and artemether-lumefantrine to treat Plasmodium falciparum infections in Swaziland: a pilot study.
    Poirot E; Soble A; Ntshalintshali N; Mwandemele A; Mkhonta N; Malambe C; Vilakati S; Pan S; Darteh S; Maphalala G; Brown J; Hwang J; Pace C; Stergachis A; Vittinghoff E; Kunene S; Gosling R
    Malar J; 2016 Jul; 15(1):384. PubMed ID: 27450652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up.
    Adjei GO; Kurtzhals JA; Rodrigues OP; Alifrangis M; Hoegberg LC; Kitcher ED; Badoe EV; Lamptey R; Goka BQ
    Malar J; 2008 Jul; 7():127. PubMed ID: 18620577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with positive malaria tests not given artemisinin-based combination therapies: a research synthesis describing under-prescription of antimalarial medicines in Africa.
    O'Boyle S; Bruxvoort KJ; Ansah EK; Burchett HED; Chandler CIR; Clarke SE; Goodman C; Mbacham W; Mbonye AK; Onwujekwe OE; Staedke SG; Wiseman VL; Whitty CJM; Hopkins H
    BMC Med; 2020 Jan; 18(1):17. PubMed ID: 31996199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug reactions in Ghanaian children: review of reports from 2000 to 2012 in VigiBase.
    Cliff-Eribo KO; Choonara I; Dodoo A; Darko DM; Sammons H
    Expert Opin Drug Saf; 2015; 14(12):1827-33. PubMed ID: 26436964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyronaridine-artesunate real-world safety, tolerability, and effectiveness in malaria patients in 5 African countries: A single-arm, open-label, cohort event monitoring study.
    Tona Lutete G; Mombo-Ngoma G; Assi SB; Bigoga JD; Koukouikila-Koussounda F; Ntamabyaliro NY; Ntoumi F; Agnandji ST; Groger M; Shin J; Borghini-Fuhrer I; Arbe-Barnes S; Allen SJ; Kremsner PG; Miller R; Duparc S; Ramharter M;
    PLoS Med; 2021 Jun; 18(6):e1003669. PubMed ID: 34129601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure to anti-malarial drugs and monitoring of adverse drug reactions using toll-free mobile phone calls in private retail sector in Sagamu, Nigeria: implications for pharmacovigilance.
    Adedeji AA; Sanusi B; Tella A; Akinsanya M; Ojo O; Akinwunmi MO; Tikare OA; Ogunwande IA; Ogundahunsi OA; Ayilara OO; Ademola TT; Fehintola FA; Ogundahunsi OA
    Malar J; 2011 Aug; 10():230. PubMed ID: 21827667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia.
    Osorio L; Gonzalez I; Olliaro P; Taylor WR
    Malar J; 2007 Feb; 6():25. PubMed ID: 17328806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adverse drug reactions (ADRs) to antimalarial drugs. Analysis of spontaneous report from the French pharmacovigilance database (1996-2000)].
    Angles A; Bagheri H; Montastruc JL; Magnaval JF;
    Presse Med; 2003 Jan; 32(3):106-13. PubMed ID: 12610379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.